VitaNova Life Sciences Corporation (VNOV) Stock Price, News & Analysis
Company Description
VitaNova Life Sciences Corporation (OTC Link: VNOV) is classified in the medical distribution industry within the Healthcare sector and carries a market capitalization of $11.5M.
For FY2025, VitaNova Life Sciences Corporation reported revenue of $2.7M with net income of $851K and diluted earnings per share of $0.03. The company operates at a net profit margin of 32.0%.
This page collects what Stock Titan holds for VNOV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VitaNova Life Sciences Corporation (VNOV) stock last closed at $1.38. At a market capitalization of $11.5M, VNOV is classified as a micro-cap stock with approximately 8.3M shares outstanding.
VNOV Rankings
Latest News
SEC Filings
VitaNova Life Sciences Corporation has filed 2 recent SEC filings, including 1 Form 8-K, 1 Form 10-Q. The most recent filing was submitted on March 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VNOV SEC filings →
Financial Highlights
VitaNova Life Sciences Corporation generated $2.7M in revenue in FY2025, retaining a 59.2% gross margin, operating income reached $1.2M (45.4% operating margin), and net income was $851K, reflecting a 32.0% net profit margin. Diluted earnings per share stood at $0.03. The company generated $193K in operating cash flow. With a current ratio of 5.90, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in VitaNova Life Sciences Corporation (VNOV) currently stands at 33 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for VitaNova Life Sciences Corporation (VNOV) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
VNOV Company Profile & Sector Positioning
VitaNova Life Sciences Corporation (VNOV) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the OTC Link.